In patients with ACC, for example, who demonstrated a reduced OS with high levels of PSMD1 expression (Figure 4A), showed exclusively amplifications as the main genomic alteration (Figure 3A). The gene discussed is PSMD1; the disease is adrenal cortex carcinoma.